In Suk Sol

In Suk Sol

Auto-generated profile, based on publicly available information

In Suk Sol

Department of Pediatrics, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2019 in Critical Care
Verified
Journal Article
Open access
PDF file
SKSoo Yeon Kim
Soo Yeon Kim
SKSaehoon Kim
Saehoon Kim
JCJoongbum Cho
Joongbum Cho
YKYoung Suh Kim
Young Suh Kim
ISIn Suk Sol
In Suk Sol
MSMyung Hyun Sohn Sohn
Myung Hyun Sohn Sohn
The rapid development in big data analytics and the data-rich environment of intensive care units together provide unprecedented opportunities for medical breakthroughs in the field of critical care. We developed and validated a machine learning-based model, the Pediatric Risk of Mortality Prediction Tool (PROMPT), for real-time prediction of all-cause mortality in pediatric intensive care units. Utilizing two separate retrospective observational cohorts, we conducted model development and validation using a machine learning algorithm with a convolutional neural network. The development cohort comprised 1445 pediatric patients with 1977 medical encounters admitted to intensive care units from January 2011 to December 2017 at Severance Hospital (Seoul, Korea). The validation cohort included 278 patients with 364 medical encounters admitted to the pediatric intensive care unit from January 2016 to November 2017 at Samsung Medical Center. Using seven vital signs, along with patient age and body weight on intensive care unit admission, PROMPT achieved an area under the receiver operating characteristic curve in the range of 0.89–0.97 for mortality prediction 6 to 60 h prior to death. Our results demonstrated that PROMPT provided high sensitivity with specificity and outperformed the conventional severity scoring system, the Pediatric Index of Mortality, in predictive ability. Model performance was indistinguishable between the development and validation cohorts. PROMPT is a deep model-based, data-driven early warning score tool that can predict mortality in critically ill children and may be useful for the timely identification of deteriorating patients.

8 January 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YCYun Jung Choi
Yun Jung Choi
ECEun Hee Chung
Eun Hee Chung
ELEun Lee
Eun Lee
CKChul-Hong Kim
Chul-Hong Kim
YLYong Ju Lee
Yong Ju Lee
DSDong In Suh
Dong In Suh
Mycoplasma pneumoniae is a major causative pathogen of community-acquired pneumonia in children, and the treatment of choice is macrolides. There is an increasing trend in reports of refractory clinical responses despite macrolide treatment due to the emergence of macrolide-resistant M. pneumoniae. Early discrimination of macrolide-refractory M. pneumoniae pneumonia (MrMP) from macrolide-sensitive M. pneumoniae pneumonia (MSMP) is vital; however, testing for macrolide susceptibility at the time of admission is not feasible. This study aimed to identify the characteristics of MrMP in Korean children, in comparison with those of MSMP. In this multicenter study, board-certified pediatric pulmonologists at 22 tertiary hospitals reviewed the medical records from 2010 to 2015 of 5294 children who were hospitalized with M. pneumoniae pneumonia and administered macrolides as the initial treatment. One-way analysis of variance and the Kruskal-Wallis test were used to compare differences between groups. Of 5294 patients (mean age, 5.6 years) included in this analysis, 240 (4.5%), 925 (17.5%), and 4129 (78.0%) had MrMP, macrolide-less effective M. pneumoniae pneumonia, and MSMP, respectively. Compared with the MSMP group, the MrMP group had a longer fever duration, overall (13.0 days) and after macrolide use (8.0 days). A higher proportion of MrMP patients had respiratory distress, pleural effusion, and lobar pneumonia. The mean aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, and C-reactive protein levels were the highest in the MrMP group, along with higher incidences of extrapulmonary manifestations and atelectasis (during and post infection). Pre-existing conditions were present in 17.4% (n = 725/4159) of patients, with asthma being the most common (n = 334/4811, 6.9%). This study verified that MrMP patients show more severe initial radiographic findings and clinical courses than MSMP patients. MrMP should be promptly managed by agents other than macrolides.

21 June 2016 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
YKYoung Hyun Kim
Young Hyun Kim
KKKyung Won Kim
Kyung Won Kim
MKMin Jung Kim
Min Jung Kim
ISIn Suk Sol
In Suk Sol
SYSeo Hee Yoon
Seo Hee Yoon
KKKyu‐Earn Kim
Kyu‐Earn Kim

31 December 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KLKeum Hwa Lee
Keum Hwa Lee
ISIn Suk Sol
In Suk Sol
JPJung Tak Park
Jung Tak Park
지김지홍 김
지홍 김
JSJae Won Shin
Jae Won Shin
Jae Il ShinJae Il Shin
Jae Il Shin
Continuous renal replacement therapy (CRRT) has been used as an important intervention in critically ill children. Our center has the only specialized CRRT team (SCT) for children in Korea, which consists of pediatric intensivists, a pediatric nephrologist and CRRT-specialized-nurses. This study was a retrospective single-center analysis, including all pediatric patients admitted to the intensive care unit (ICU) of Severance hospital in Korea and received CRRT between 2003 and 2016, grouped as before SCT (group A, n = 51) and after SCT (group B, n = 212). We obtained the data for sex, age, weight, diagnosis, blood flow rate or type of CRRT machine used, administration of inotropic agents or anticoagulants, and ICU duration before CRRT (hours). A total of 263 patients were included. The age was significantly younger (p < 0.001) and blood flow rate was lower (p = 0.001) in group B than group A. Vasopressors (p < 0.001), continuous veno-venous hemodiafiltration (CVVHDF) (p < 0.001), nafamostat mesilate (p < 0.001), and extracorporeal membrane oxygenation (ECMO)-CRRT (p = 0.004) were more frequently used in group B. Based on our 14-year experience, we conclude that SCT operation could have played an important role in increasing the amount of CRRT utilization.

8 February 2018 in Allergy
Verified
Journal Article
Open access
PDF file
JHJung Yeon Hong
Jung Yeon Hong
MKMina Kim
Mina Kim
ISI. S. Sol
I. S. Sol
KKKyung Won Kim
Kyung Won Kim
CLC.‐M. Lee
C.‐M. Lee
CLChun Geun LEE
Chun Geun LEE
Background: Chitotriosidase (chitinase 1, Chit1), a major true chitinase in humans, is induced in childhood asthma and has been implicated in the pathogenesis of a variety of inflammatory and tissue remodeling responses. However, the role and the mechanisms that underlie these contributions to the diseases have not been defined. We hypothesized that Chit1 plays a significant role in the pathogenesis of allergic asthma.Methods: Wild‐type and Chit1‐deficient mice and cells in culture were used to define the roles of Chit1 in models of allergic adaptive Th2 inflammation. In addition, the levels of sputum Chit1 were evaluated in pediatric asthma patients and compared to control.Results: The levels of sputum Chit1 were significantly increased in the patients with childhood asthma. Mice with Chit1 null mutation demonstrated enhanced allergic Th2 inflammatory and cytokine and IgE responses to OVA or house dust mite allergen sensitization and challenge. However, the expression levels of TGF‐β1 were significantly decreased with a diminished number of Foxp3+ regulatory T cells (Treg) in the lungs of Chit1−/− mice compared to WT controls. In vitro, the absence of Chit1 significantly reduced TGF‐β‐stimulated conversion of CD4+CD25− naïve T cells to CD4+Foxp3+ Treg cells, suggesting Chit1 is required for optimal effect of TGF‐β1 in Treg cell differentiation.Conclusion: Chit1 plays a protective role in the pathogenesis of allergic inflammation and asthmatic airway responses via regulation of TGF‐β expression and Foxp3+ Treg cells.

3 May 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MKMin Jung Kim
Min Jung Kim
YKYoung Hyun Kim
Young Hyun Kim
ISIn Suk Sol
In Suk Sol
SKSoo Yeon Kim
Soo Yeon Kim
JKJong Deok Kim
Jong Deok Kim
KKKyu-Earn Kim
Kyu-Earn Kim
An accurate method to predict the mortality in the intensive care unit (ICU) patients has been required, especially in children. The aim of this study is to evaluate the value of serum anion gap (AG) for predicting mortality in pediatric ICU (PICU). We reviewed a data of 461 pediatric patients were collected on PICU admission. Corrected anion gap (cAG), the AG compensated for abnormal albumin levels, was significantly lower in survivors compared with nonsurvivors (p < 0.001). Multivariable logistic regression analysis identified the following variables as independent predictors of mortality; cAG (OR 1.110, 95% CI 1.06–1.17;p < 0.001), PIM3 [OR 7.583, 95% CI 1.81–31.78;p = 0.006], and PRISM III [OR 1.076, 95% CI 1.02–1.14;p = 0.008]. Comparing AUCs for mortality prediction, there were no statistically significant differences between cAG and other mortality prediction models; cAG 0.728, PIM2 0.779, PIM3 0.822, and PRISM III 0.808. The corporation of cAG to pre-existing mortality prediction models was significantly more accurate at predicting mortality than using any of these models alone. We concluded that cAG at ICU admission may be used to predict mortality in children, regardless of underlying etiology. And the incorporation of cAG to pre-existing mortality prediction models might improve predictability.